MEDICINE DETAILS
Biktarvy
Active ingredient: Bictegravir Emtricitabine Tenofovir Alafenamide
Biktarvy is recorded in this directory with the active ingredient Bictegravir Emtricitabine Tenofovir Alafenamide. This page brings together catalogue strength, dosage-form and pack records so they can be checked against a prescription.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Biktarvy used for?
Biktarvy is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection. It is only used in patients where the virus has not developed resistance to a class of HIV medicines called integrase inhibitors, or to tenofovir or emtricitabine.
Biktarvy is available as tablets, each containing 50 mg bictegravir, 200 mg emtricitabine, and 25 mg tenofovir alafenamide. The recommended dose is one tablet a day.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Biktarvy identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
30 mg/120 mg/15 mg · 30 tablets Catalogue organisation: Gilead Sciences GmbH
-
30 mg/120 mg/15 mg · 90 tablets Catalogue organisation: Gilead Sciences GmbH
-
50 mg/200 mg/25 mg · 30 tablets Catalogue organisation: Gilead Sciences GmbH
-
50 mg/200 mg/25 mg · 90 tablets Catalogue organisation: Gilead Sciences GmbH
OFFICIAL SOURCES
Check the Biktarvy record at an official source.
Search for “Biktarvy” or “Bictegravir Emtricitabine Tenofovir Alafenamide”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Biktarvy.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Biktarvy
01What is Biktarvy?＋
This directory record associates the brand name Biktarvy with the active ingredient Bictegravir Emtricitabine Tenofovir Alafenamide. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Biktarvy strengths and packs are recorded?＋
The catalogue currently shows: 30 mg/120 mg/15 mg · 30 tablets; 30 mg/120 mg/15 mg · 90 tablets; 50 mg/200 mg/25 mg · 30 tablets; 50 mg/200 mg/25 mg · 90 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Biktarvy?＋
Catalogue records currently name: Gilead Sciences GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Biktarvy?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Biktarvy, payment request, stock guarantee or binding offer.
06Can I buy Biktarvy from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.